• Issue

    Liver: Volume 20, Issue 4

    271-350
    August 2000
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Article

Full Access

A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients

Yasushi Shiratori,  Mistuhiko Moriyama,  Fumio Imazeki,  Hitoshi Ohkubo,  Naohide Tanaka,  Yasuyuki Arakawa,  Haruhiko Yoshida,  Osamu Yokosuka,  Akitaka Shibuya,  Kohei Matsuzaki,  Etsuko Hashimoto,  Naoaki Hayashi,  Keiichi Hirata,  Yasuo Ohashi,  Masao Omata,  (Tokyo-Chiba Hepatitis Research Group) , 
  • Pages: 271-280
  • First Published: 24 December 2001
Full Access

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

Sanaa Kamal,  Mohamed Madwar,  Leonardo Bianchi,  Ahmed E. L. Tawil,  Ragaa Fawzy,  Thomas Peters,  Jens W. F. Rasenack, 
  • Pages: 281-289
  • First Published: 24 December 2001
Full Access

Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma

Iwao Yabuuchi,  Yasuharu Imai,  Sumio Kawata,  Shinji Tamura,  Shuzo Noda,  Masami Inada,  Yuichi Maeda,  Yasuhiro Shirai,  Takaaki Fukuzaki,  Itaru Kaji,  Hideki Ishikawa,  Yukihiko Matsuda,  Masahiro Nishikawa,  Kouichi Seki,  Yuji Matsuzawa, 
  • Pages: 290-295
  • First Published: 24 December 2001
Full Access

Connective tissue growth factor in human liver cirrhosis

Mohamed Abou-Shady,  Helmut Friess,  Arthur Zimmermann,  Fabio F. Di Mola ,  Xiao-Zhong Guo,  Hans U. Baer,  Markus W. Büchler, 
  • Pages: 296-304
  • First Published: 24 December 2001
Full Access

Role of serum soluble Fas/soluble Fas ligand and TNF-α on response to interferon-α therapy in chronic hepatitis C

Mitsuo Toyoda,  Satoru Kakizaki,  Norio Horiguchi,  Ken Sato,  Hisashi Takayama,  Hitoshi Takagi,  Takeaki Nagamine,  Masatomo Mori, 
  • Pages: 305-311
  • First Published: 24 December 2001
Full Access

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area

Stefan Kubicka,  Karl Lenhard Rudolph,  Martina Hanke,  Maja Katrin Tietze,  Hans Ludger Tillmann,  Christian Trautwein,  Michael Manns, 
  • Pages: 312-318
  • First Published: 24 December 2001
Full Access

Inhibition of lipopolysaccharide-induced I-κB degradation and tumor necrosis factor-α expression by dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression

Sang Geon Kim,  Hye Jung Kim,  Sung Hee Choi,  Ji Yeun Ryu, 
  • Pages: 319-329
  • First Published: 24 December 2001
Full Access

Plasma elimination of cholyl-lysyl-fluorescein (CLF): a pilot study in patients with liver cirrhosis

Piotr Milkiewicz,  Sushma Saksena,  Teresa Cardenas,  Charles O. Mills,  Elwyn Elias, 
  • Pages: 330-334
  • First Published: 24 December 2001
Full Access

Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis

Abraham Koshy,  Patrick Marcellin,  Michele Martinot,  John P. Madda, 
  • Pages: 335-339
  • First Published: 24 December 2001

Case Report

Full Access

Sequential occurrence of primary sclerosing cholangitis and autoimmune hepatitis type III in a patient with ulcerative colitis: a follow up study over 14 years

Wolfram Domschke,  Reinhild Klein,  Luigi-Maria Terracciano,  Peter Jung,  Thomas Kirchner,  Peter A. Berg,  Leonardo Bianchi, 
  • Pages: 340-345
  • First Published: 24 December 2001
Full Access

Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure

Stephan Krähenbühl,  Sebastian Brandner,  Stephanie Kleinle,  Sabina Liechti,  Dominik Straumann, 
  • Pages: 346-348
  • First Published: 24 December 2001

Book Review

Full Access

Book Review

  • Page: 349
  • First Published: 24 December 2001

Announcement

Full Access

Announcements

  • Page: 350
  • First Published: 24 December 2001